Intranasal delivery of extracellular vesicles derived from neural stem cells reduced oxidative stress, restored mitochondrial function, enhanced cellular cleanup mechanisms, and increased neurogenesis in an Alzheimer's disease model. The treatment addressed multiple pathological mechanisms simultaneously—mitochondrial dysfunction, excessive mTOR signaling, impaired autophagy, and diminished neurogenesis—suggesting potential disease-modifying capacity in early-stage cognitive decline.
Key Points
- Restored mitochondrial biogenesis and electron transport chain function in treated mice
- Reduced oxidative stress and mTOR signaling while enhancing autophagy pathways
- Increased hippocampal neurogenesis with elevated brain-derived neurotrophic factor activity
Longevity Analysis
This work demonstrates that therapeutic intervention targeting energy production and cellular maintenance can reverse multiple convergent pathologies in neurodegeneration. The treatment improved how cells generate ATP, clear damaged mitochondria, regulate growth signaling, and generate new neurons—interconnected processes that degrade together in cognitive decline. Early intervention at these nodes before irreversible damage accumulates may substantially alter disease trajectory. The mechanism bypasses pharmaceutical targeting of single pathways, instead supporting the body's inherent regenerative capacity through a biologically sophisticated delivery vehicle.
Original published by Wiley Aging Cell, by Leelavathi N. Madhu, Sahithi Attaluri, Sanya Kotian, Raghavendra Upadhya, Yogish Somayaji, Shama Rao, Prashant Tarale, Shruthi V. Ganesh, Charles Huard, Maheedhar Kodali, Bing Shuai, Vidya V. Rao, Ashok K. Shetty .